Skip to content
Global markets · Independent coverage Follow a hub and receive new coverage by email.
TechStock2Market intelligence
Signalbook

NASDAQ:KZIA

Kazia Therapeutics Drops 7.3% With $40 Million Offering After Clinical Data Surge

Kazia Therapeutics Limited dropped 7.34% to $15.66 ahead of Friday's session. The cancer drug company announced a $40 million equity sale following a significant surge driven by clinical trial results.

3 min read
NASDAQ:KZIAPharmaceuticalsStock Market

Company hubNASDAQ:KZIA

Kazia Therapeutics (KZIA) Stock News & Analysis

Follow the latest Kazia Therapeutics (KZIA) company news, earnings coverage and investor analysis from TechStock².

Save this hub to your TS2 Signalbook account.
Latest update
Articles in this hub
2
Last 30 days
1

What investors are watching

  • Earnings, guidance and financial performance
  • Valuation, trading activity and market sentiment
  • Strategy, catalysts and company-specific risks
Read latest coveragePrefer TechStock² in Google

All coverage

NASDAQ:KZIA

2 articles